Home/ Supplements/ Omega 3/ Omega 3-6-9 Complex

Omega 3-6-9 Complex

product on market Softgel Capsule Natrol Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Omega-3 fish oil and flax oil provide essential fatty acids that support cardiovascular health and inflammatory responses. There is strong clinical evidence for the benefits of omega-3s, while evidence for omega-6 and 9 supplementation is more limited. These ingredients are generally recognized as safe for consumption.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Omega 3-6-9 Complex
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
60
Servings
Fat/Fatty Acid
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
15 {Calories}
Total Fat
1.5 Gram(s) (2% DV)
Cholesterol
5 mg (2% DV)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
400 mg
Market median: 1000.0mg (212 products) 12 studies (A:0, B:3)
Borage Oil
400 mg

Other Ingredients

Gelatin Glycerin Water Mixed Tocopherols natural Lemon Oil
Claims

Label Claims — Verification

Unverified Nutrient
Info

Product Information

Directions for Use

Directions: Take 1 softgel, two times daily, with a meal.

Formulation Notes

Fish, Flax and Borage Oil - With Fish Oil Distilled for Purity

Additional Information

- Lemon Flavor

Metadata

Product Details

DSLD Entry Date2013-10-25
Product TypeFat/Fatty Acid
FormSoftgel Capsule
BrandNatrol
DSLD ID26950
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.